Cargando…
Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy
Coronary artery disease represents the leading cause of mortality in the developed world. Percutaneous coronary intervention (PCI) involving stent placement remains disadvantaged by restenosis or thrombosis. Vascular gene-therapy-based methods may be approached, but lack a vascular gene delivery vec...
Autores principales: | Lompré, Anne-Marie, Hadri, Lahouaria, Merlet, Elise, Keuylian, Zela, Mougenot, Nathalie, Karakikes, Ioannis, Chen, Jiqiu, Atassi, Fabrice, Marchand, Alexandre, Blaise, Regis, Limon, Isabelle, McPhee, Scott W.J., Samulski, Richard J., Hajjar, Roger J., Lipskaia, Larissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706517/ https://www.ncbi.nlm.nih.gov/pubmed/23535897 http://dx.doi.org/10.1038/gt.2013.13 |
Ejemplares similares
-
Inhalable delivery of AAV-based MRP4/ABCC4 silencing RNA prevents monocrotaline-induced pulmonary hypertension
por: Claude, Caroline, et al.
Publicado: (2015) -
SERCA2a gene transfer prevents intimal proliferation in an organ culture of human internal mammary artery
por: Lipskaia, Larissa, et al.
Publicado: (2012) -
Gene Remodeling in Type 2 Diabetic Cardiomyopathy and Its Phenotypic Rescue with SERCA2a
por: Karakikes, Ioannis, et al.
Publicado: (2009) -
Direct Interaction of Human Serum Proteins with AAV Virions to Enhance AAV Transduction: Immediate Impact on Clinical Applications
por: Wang, Mei, et al.
Publicado: (2016) -
ReGeneraTing Agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb
por: Roohi, Sharifah Ahmad, et al.
Publicado: (2021)